News
| 9:14 AM | Zacks Research|Outperform on $ABMD http://stks.co/2LaK by abubnic |
| 4:18AM | Ignore: Nasdaq Short Interest Tables |
| Feb 09 | Largest Nasdaq Short Interest Percent Decreases as of Jan. 31 |
| Feb 09 | Largest Nasdaq Short Interest Percent Increases as of Jan. 31 |
| Feb 09 | Largest Nasdaq Short Interest Changes as of Jan. 31 |
| Feb 09 | Outperform on Abiomed |
| Feb 09 | Outperform on Abiomed - Analyst Blog Zacks |
| Feb 09 | $ABMD filed latest Quarterly Report http://stks.co/2L0h by MarketBrief |
| Feb 09 | $ABMD up premrk. Still has some mojo this morning. by ssmith98 |
| Feb 08 | $AAPL http://stks.co/2Jj1 This market leader cont's to lead $BAC $BIDU $NKE $PCLN $CF $ABMD $CMG $V $MA $SAVE POSTED VIDEO by TraderFlorida |
| Feb 08 | Great push into the close $abmd added to position on pull back today. by ssmith98 |
Profile
Exchange: NASDAQGM Sector: Healthcare Industry: Medical Appliances & Equipment
Abiomed, Inc. provides medical devices in circulatory support and continuum of care in heart recovery to acute heart failure patients. Its products consist of Impella 2.5 catheter, a percutaneous micro heart pump with integrated motor and sensors for use in interventional cardiology; and Impella 5.0 catheter and Impella LD, which are percutaneous micro heart pumps with integrated motors and sensors for use primarily in the heart surgery suite. The company also manufactures and sells the AB5000 circulatory support system and the BVS 5000 biventricular support system for temporary support of acute heart failure patients in profound shock, including patients suffering from cardiogenic shock after a heart attack, post-cardiotomy cardiogenic shock, or myocarditis. In addition, it offers AbioCor implantable replacement heart, a self-contained artificial heart for end-stage biventricular heart failure patients. The company was founded in 1981 and is based in Danvers, Massachusetts.
1 Year Total Return Performance
This total returns chart shows the returns to an investor from both price appreciation and dividends (dividends are assumed to be reinvested). ABIOMED is up N/A over the last year vs S&P 500 Total Return up N/A, Edwards Lifesciences down N/A, and World Heart Corporation down N/A.
- ABMD Total Returns
- ^SPXTR Total Returns
- EW Total Returns
- WHRT Total Returns
Fundamentals
Fundamental analysis of a business involves analyzing its financial statements and health, its management and competitive advantages. The key financial statements of a company are the income statement, balance sheet and cash flow statement.
Cash Flow Statement View Statement
You may also be interested in these ABMD related companies
Pro Strategies Featuring ABMD
Did ABIOMED make it into our Pro Portfolio Strategies?
ABMD Charts
- Accounts Payable
- Accounts Receivable
- Accruals Pro
- Altman Z-Score Pro
- Asset Utilization
- Beneish M-Score Pro
- Beta Pro
- Book Value
- Book Value per Share
- Capital Expenditures
- Cash Conversion Cycle Pro
- Cash Div. Payout Ratio TTM Pro
- Cash Financing
- Cash Financing TTM
- Cash Investing
- Cash Investing TTM
- Cash Operations
- Cash Operations TTM
- Cash and Equivalents
- Cash and ST Investments
- Current Ratio
- Days Inventory Outstanding Pro
- Days Payable Outstanding Pro
- Days Sales Outstanding Pro
- Debt to Equity Ratio
- Dividend
- Dividend Yield
- EBITDA Margin TTM Pro
- EBITDA TTM Pro
- EV / EBIT Pro
- EV / EBITDA Pro
- EV / Free Cash Flow Pro
- EV / Revenues Pro
- Earnings Per Share
- Earnings Per Share Growth
- Earnings Per Share TTM
- Earnings Yield
- Effective Tax Rate TTM Pro
- Enterprise Value
- Expenses
- Expenses TTM
- Free Cash Flow
- Free Cash Flow TTM
- Free Cash Flow Yield Pro
- Fundamental Score Pro
- Gross Profit Margin
- Gross Profit TTM
- Income from Cont. Ops Pro
- Interest Expense
- Interest Income
- Inventories
- KZ Index Pro
- Liabilities
- Long Term Debt
- Market Cap
- Net Income
- Net Income TTM
- Net PP&E
- Operating Earnings Yield Pro
- Operating Margin TTM Pro
- Operating PE Ratio Pro
- Other Comprehensive Income Pro
- PE 10 Pro
- PE Ratio
- PE Value Pro
- PEG Ratio
- PS Value Pro
- Payout Ratio TTM Pro
- Price
- Price / Book Value
- Price / Sales Ratio
- Price / Tangible Book Value Pro
- Profit Margin
- R&D Expense
- Receivables Turnover
- Retained Earnings
- Retained Earnings Growth
- Return on Assets
- Return on Equity
- Return on Invested Capital Pro
- Revenue Growth
- Revenue Per Share TTM
- Revenues
- Revenues TTM
- SG&A Expense
- Shareholders Equity
- Shares Outstanding
- Stock Buybacks
- Tangible Book Value Pro
- Tangible Book Value Per Share Pro
- Tangible Common Equity Ratio Pro
- Times Interest Earned TTM Pro
- Total Assets
- Total Return Price
- Valuation (Historical Mult.) Pro
- Valuation Percentage Pro
- Value Score Pro
Other ABMD Resources
- Company Website
- Wiki Page
- Investor Relations
- 13F Filings Whale Wisdom
- Call Transcripts Seeking Alpha
- Insider Trading Quote.com
- Institutional Ownership MSN Money
- SEC Filings SEC
- Technical Charts Chart.ly
- Trading Ideas Benzinga
Recent Quotes
| Symbol | Price | Chg | Chg % | Market Cap |
|---|---|---|---|---|
| ABMD | 22.80 | -0.39 | -1.68% | 894.44M |
| MSCC | 21.55 | -0.33 | -1.51% | 1.91B |
| HAIN | 40.02 | -0.64 | -1.57% | 1.77B |
| VASC | 10.81 | -0.04 | -0.37% | 184.78M |
| JKHY | 34.45 | -0.39 | -1.12% | 3.02B |
| IDSA | 6.47 | 0.00 | 0.00% | 44.90M |
| SNMX | 3.37 | -0.03 | -0.88% | 134.78M |
| EXLP | 22.31 | -0.59 | -2.58% | 744.71M |
| ARLP | 73.98 | -0.31 | -0.42% | 2.73B |
| HOOK | 6.37 | 0.07 | 1.11% | 118.69M |
